Professor Parry Guilford is a Principal Investigator in the Cancer Genetics Laboratory, University of Otago, Dunedin, New Zealand, and the Research Director of Pacific Edge Biotechnology Ltd. He completed his MSc at Otago in 1983, and his PhD at Cambridge University in 1989. His research interests include the genetics of inherited cancers, in particular gastric cancer, and the application of gene expression analysis to the diagnosis and management of cancer.
Ingrid P Vogelaar, Rachel S van der Post, Fatima Carneiro, Parry Guilford, David Huntsman, Nicoline Hoogerbrugge, Carlos Caldas, Karen E Chelcun Schreiber, Richard H Hardwick, Margreet G E M Ausems, Linda Bardram, Patrick R Benusiglio, Tanya M Bisseling, Vanessa Blair, Eveline Bleiker, Alex Boussioutas, Annemieke Cats, Daniel Coit, Lynn DeGregorio, Joana Figueiredo, James M Ford, Esther Heijkoop, Rosella Hermens, Bostjan Humar, Pardeep Kaurah, Gisella Keller, Jennifer Lai, Marjolijn J L Ligtenberg, Maria O'Donovan, Carla Oliveira, Hugo Pinheiro, Krish Ragunath, Esther Rasenberg, Susan Richardson, Franco Roviello, Hans Schackert, Raquel Seruca, Amy Taylor, Anouk Ter Huurne, Marc Tischkowitz, Sheena Tjon A Joe, Benjamin van Dijck, Nicole C T van Grieken, Richard van Hillegersberg, Johanna W van Sandick, Rianne Vehof, J Han Van Krieken, and Rebecca C Fitzgerald., Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers., Journal of medical genetics 2015, Link »
Bryony J Telford, Augustine Chen, Henry Beetham, James Frick, Tom P Brew, Cathryn M Gould, Andrew Single, Tanis Godwin, Kaylene J Simpson, and Parry Guilford., Synthetic lethal screens identify vulnerabilities in GPCR signalling and cytoskeletal organization in E-cadherin-deficient cells., Molecular Cancer Therapeutics 2015., Link »
Augustine Chen, Henry Beetham, Michael A Black, Rashmi Priya, Bryony J Telford, Joanne Guest, George A R Wiggins, Tanis D Godwin, Alpha S Yap, and Parry J Guilford, E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition., BMC cancer 2014 vol. 14 p. 552, Link »
Jon Cornwall, Tania Slatter, Parry Guilford, Cristin G. Print, Mark Henaghan, and Richman Wee, Culture, law, ethics, and social implications: Is society ready for advanced genomic medicine?, The Australasian medical journal 2014 vol. 7 (4) pp. 200-202, Link »
J S B Willson, T D Godwin, G A R Wiggins, P J Guilford, and J L McCall, Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation, Journal of Hepatology 2013 vol. 59 (4) pp. 904-907, Link »
P O'Sullivan, K Sharples, M Dalphin, P. Davidson, P Gilling, L Cambridge, J Harvey, T Toro, N Giles, C Luxmanan, C F Alves, H-S Yoon, V Hinder, J Masters, A Kennedy-Smith, T Beaven, and P J Guilford, A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria, Journal of Urology 2012 vol. 188 (3) pp. 741-747, Link »